Clinical trials: Transfusion Hemosiderosis

Anemia, Sickle Cell, Transfusion Hemosiderosis

Clinical Importance of Treating Iron Overload in Sickle Cell Disease

• Terminated
• Age: 14 years and older
• Phase 3
• Results posted

Hypothesis: The investigators suspect that significant degrees of iron overload in subjects with SCD result in decreased red cell survival, abnormal endothelial function and markedly dysregulated autonomic function.

Trial name

NCT00981370

Testing

deferasirox

Where

United States

Volunteers

1 people

Sponsor

Children's Hospital Los Angeles